Immune Checkpoint Inhibitor–related Colitis in Patients on Immunotherapy for Cancer

Immune Checkpoint Inhibitor–related Colitis in Patients on Immunotherapy for Cancer is organized by American Society for Clinical Pathology (ASCP).

Upon completion of this activity, you will be able to:
• Describe the general mechanism of immune checkpoint inhibitors.
• Outline the range of symptoms, endoscopic presentation, and time courses of presentation of colitis in patients on immune checkpoint inhibitors.
• List the common types of histological changes that can be observed in colonic biopsies from patients being treated with immune checkpoint inhibitors